Literature DB >> 7541879

Role of nitric oxide in human esophageal circular smooth muscle in vitro.

W G Richards1, J S Stamler, L Kobzik, D J Sugarbaker.   

Abstract

The role of nitric oxide in human esophageal smooth muscle was examined. Immunostaining for constitutive nitric oxide synthase labeled nerve fibers and bundles within longitudinal and circular smooth muscle layers of resected tissue samples. Strips of circular muscle mounted in organ baths exhibited spontaneous contractions and active tone. When exposed to 5-second trains of electric field stimulation at 20 Hz, most strips exhibited intrastimulus "on" and poststimulus "off" contractions. Exposure to a 0.1 mumol/L (or greater) concentration of atropine converted "on" contractions to "on" relaxations and reduced "off" contractions by 63%. Exposure to NG-nitro-L-arginine resulted in concentration-dependent enhancement of "on" contractions and abolition of "off" contractions. Excess L-arginine enhanced the reversal of these effects. Sodium nitroprusside inhibited both spontaneous and evoked contractions. These results suggest that nitric oxide synthesis is a mediator of neural inhibition of human esophageal circular smooth muscle and is necessary for the occurrence of "off" contractions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541879     DOI: 10.1016/S0022-5223(05)80021-2

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

Review 1.  Neuromuscular control of esophageal peristalsis.

Authors:  H Park; J L Conklin
Journal:  Curr Gastroenterol Rep       Date:  1999-06

2.  Effect of amino acids on lower esophageal sphincter characteristics and gastroesophageal reflux in humans.

Authors:  H A Gielkens; C B Lamers; A A Masclee
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

Review 3.  Translational neuropharmacology: the use of human isolated gastrointestinal tissues.

Authors:  G J Sanger; J Broad; V Kung; C H Knowles
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.